Safety and Mechanism of Action of Licensed Vaccine Adjuvants.

Rambe, Dirga Sakti; Giudice, Giuseppe Del; Rossi, Stefania; Sanicas, Melvin.
Artículo en Inglés | IMSEAR | ID: sea-174304

Documentos relacionados

  1. Safety and Mechanism of Action of Licensed Vaccine Adjuvants.
  2. Suitability and perspectives on using recombinant insect cells for the production of virus-like particles.
  3. [Heterogeneity in psychiatry training in Europe: competition or collaboration?]
  4. Correlative imaging using super-resolution fluorescence microscopy and soft X-ray tomography at cryogenic temperatures provides a new way to assess virosome solutions for vaccine development.
  5. Adverse events of vaccines and the consequences of non-vaccination: a critical review
  6. [Mental Health Situation of Sex Workers in Europe: a Scoping Review].
  7. [The Image of Doctors in Europe: A Comparison of Countries].
  8. Optimized production of HIV-1 virus-like particles by transient transfection in CAP-T cells.
  9. [HTA goes Europe: European collaboration on joint assessment and methodological issues becomes reality].
  10. Interaction of Human Parainfluenza Virus Type 3 Nucleoprotein with Matrix Protein Mediates Internal Viral Protein Assembly.